Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation With Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate

NCT01230866 is registered in ClinicalTrials.gov with Proton Collaborative Group as lead sponsor.

NCT NCT01230866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01230866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation With Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate
Lead sponsor
Proton Collaborative Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 30, 2010
Completion date
Not reported
Enrollment
150 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer